135 related articles for article (PubMed ID: 31602686)
21. Mutations and interactions in human ERα and bZIP proteins: An in silico approach for cell signaling in breast oncology.
Banerjee A; Ray S
Gene; 2017 Apr; 610():90-102. PubMed ID: 28111258
[TBL] [Abstract][Full Text] [Related]
22. Definition of functionally important mechanistic differences among selective estrogen receptor down-regulators.
Wittmann BM; Sherk A; McDonnell DP
Cancer Res; 2007 Oct; 67(19):9549-60. PubMed ID: 17909066
[TBL] [Abstract][Full Text] [Related]
23. A computational study of potent series of selective estrogen receptor degraders for breast cancer therapy.
Zekri A; Harkati D; Kenouche S; Saleh BA; Alnajjar R
J Biomol Struct Dyn; 2023 Dec; 41(20):11078-11100. PubMed ID: 36537313
[TBL] [Abstract][Full Text] [Related]
24. Ligand and structure based virtual screening of chemical databases to explore potent small molecule inhibitors against breast invasive carcinoma using recent computational technologies.
Agarwal S; Dixit A; Kashaw SK
J Mol Graph Model; 2020 Jul; 98():107591. PubMed ID: 32234678
[TBL] [Abstract][Full Text] [Related]
25. The 2.0 A crystal structure of the ERalpha ligand-binding domain complexed with lasofoxifene.
Vajdos FF; Hoth LR; Geoghegan KF; Simons SP; LeMotte PK; Danley DE; Ammirati MJ; Pandit J
Protein Sci; 2007 May; 16(5):897-905. PubMed ID: 17456742
[TBL] [Abstract][Full Text] [Related]
26. Structural and binding insights into HIV-1 protease and P2-ligand interactions through molecular dynamics simulations, binding free energy and principal component analysis.
Karnati KR; Wang Y
J Mol Graph Model; 2019 Nov; 92():112-122. PubMed ID: 31351319
[TBL] [Abstract][Full Text] [Related]
27. Molecular dynamics simulation and free energy landscape methods in probing L215H, L217R and L225M βI-tubulin mutations causing paclitaxel resistance in cancer cells.
Tripathi S; Srivastava G; Sharma A
Biochem Biophys Res Commun; 2016 Aug; 476(4):273-279. PubMed ID: 27233604
[TBL] [Abstract][Full Text] [Related]
28. The Interaction of Isoflavone Phytoestrogens with ER
Wang T; Liu Y; Zhuang X; Luan F; Zhao C
Curr Comput Aided Drug Des; 2021; 17(5):655-665. PubMed ID: 32652920
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and evaluation of tamoxifen derivatives with a long alkyl side chain as selective estrogen receptor down-regulators.
Shoda T; Kato M; Harada R; Fujisato T; Okuhira K; Demizu Y; Inoue H; Naito M; Kurihara M
Bioorg Med Chem; 2015 Jul; 23(13):3091-6. PubMed ID: 26003343
[TBL] [Abstract][Full Text] [Related]
30. Differential binding of prohibitin-2 to estrogen receptor α and to drug-resistant ERα mutants.
Chigira T; Nagatoishi S; Tsumoto K
Biochem Biophys Res Commun; 2015 Aug; 463(4):726-31. PubMed ID: 26049107
[TBL] [Abstract][Full Text] [Related]
31. Targeting protein tyrosine phosphatase to unravel possible inhibitors for Streptococcus pneumoniae using molecular docking, molecular dynamics simulations coupled with free energy calculations.
Zaman Z; Khan S; Nouroz F; Farooq U; Urooj A
Life Sci; 2021 Jan; 264():118621. PubMed ID: 33164832
[TBL] [Abstract][Full Text] [Related]
32. Nonsteroidal estrogen receptor isoform-selective biphenyls.
Bhatnagar S; Soni A; Kaushik S; Rikhi M; Santhoshkumar TR; Jayaram B
Chem Biol Drug Des; 2018 Feb; 91(2):620-630. PubMed ID: 29052968
[TBL] [Abstract][Full Text] [Related]
33. Potential activity of fevicordin-A from Phaleria macrocarpa (Scheff) Boerl. seeds as estrogen receptor antagonist based on cytotoxicity and molecular modelling studies.
Muchtaridi M; Yusuf M; Diantini A; Choi SB; Al-Najjar BO; Manurung JV; Subarnas A; Achmad TH; Wardhani SR; Wahab HA
Int J Mol Sci; 2014 Apr; 15(5):7225-49. PubMed ID: 24776765
[TBL] [Abstract][Full Text] [Related]
34. Cross-talk between the ligand- and DNA-binding domains of estrogen receptor.
Huang W; Greene GL; Ravikumar KM; Yang S
Proteins; 2013 Nov; 81(11):1900-9. PubMed ID: 23737157
[TBL] [Abstract][Full Text] [Related]
35. New computational strategy to analyze the interactions of ERalpha and ERbeta with different ERE sequences.
Marabotti A; Colonna G; Facchiano A
J Comput Chem; 2007 Apr; 28(6):1031-41. PubMed ID: 17269124
[TBL] [Abstract][Full Text] [Related]
36. Determination and analysis of agonist and antagonist potential of naturally occurring flavonoids for estrogen receptor (ERα) by various parameters and molecular modelling approach.
Puranik NV; Srivastava P; Bhatt G; John Mary DJS; Limaye AM; Sivaraman J
Sci Rep; 2019 May; 9(1):7450. PubMed ID: 31092862
[TBL] [Abstract][Full Text] [Related]
37. Discovery of novel natural compound inhibitors targeting estrogen receptor α by an integrated virtual screening strategy.
Yu E; Xu Y; Shi Y; Yu Q; Liu J; Xu L
J Mol Model; 2019 Aug; 25(9):278. PubMed ID: 31463793
[TBL] [Abstract][Full Text] [Related]
38. Multiple receptor conformers based molecular docking study of fluorine enhanced ethionamide with mycobacterium enoyl ACP reductase (InhA).
Khan AM; Shawon J; Halim MA
J Mol Graph Model; 2017 Oct; 77():386-398. PubMed ID: 28957755
[TBL] [Abstract][Full Text] [Related]
39. Exploring the molecular mechanism of cross-resistance to HIV-1 integrase strand transfer inhibitors by molecular dynamics simulation and residue interaction network analysis.
Xue W; Jin X; Ning L; Wang M; Liu H; Yao X
J Chem Inf Model; 2013 Jan; 53(1):210-22. PubMed ID: 23231029
[TBL] [Abstract][Full Text] [Related]
40. Binding of quinazolinones to c-KIT G-quadruplex; an interplay between hydrogen bonding and π-π stacking.
Moghaddam KG; de Vries AH; Marrink SJ; Faraji S
Biophys Chem; 2019 Oct; 253():106220. PubMed ID: 31302375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
